Emerging evidence suggests that fibrinogen-to-albumin ratio (FAR), as a novel inflammatory biomarker, is significantly associated with AKI, potentially mediated through its reflection of microinflammatory states, oxidative stress pathways, and endothelial dysfunction implicated in both glomerular and tubular damage [9]. This evidence concerns the gene ALB and acute kidney injury.